Status:
UNKNOWN
New Markers for Diagnosis of Prosthetic Infections
Lead Sponsor:
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions:
Prosthetic Joint Infections
Eligibility:
All Genders
18+ years
Brief Summary
Implant infections are among the most dramatic complications in orthopaedic surgery with heavy impact on life quality and health system. Their diagnosis is still challenging since, till now, none othe...
Detailed Description
Management of prosthetic joint infections involves long antibiotic therapy and, in most cases, additional revision surgery with worsening of life quality for patients and high costs for health system....
Eligibility Criteria
Inclusion
- Patients with diagnosis of septic or aseptic failure of prosthetic implant
- Informed consent signed
Exclusion
- Patients undergoing revision surgery for failure not due to the above mentioned causes
- Known auto immune diseases or other conditions which might alter inflammatory response
Key Trial Info
Start Date :
September 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2020
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT03769337
Start Date
September 1 2018
End Date
September 30 2020
Last Update
December 24 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Istituto Ortopedico Galeazzi
Milan, MI, Italy, 20161